Advertisement

Biofeedback pp 81-121 | Cite as

Clinical Issues in Biofeedback and Relaxation Therapy for Hypertension

Review and Recommendations
  • Michael S. Glasgow
  • Bernard T. Engel

Abstract

Blood pressure (BP) is maintained by cardiac output and peripheral vascular resistance that, in turn, are modified by stroke volume, pulse rate, total blood volume, blood viscosity, elasticity of blood vessels, and humoral and neurogenic stimuli. Changes in one or more of these variables by pharmacological, behavioral, physiological, or environmental means normally affect BP only transiently because a variety of homeostatic reflexes, responding to the change, act to maintain a relatively stable mean arterial BP. When a homeostatic mechanism chronically maintains BP at abnormally high levels, it is sometimes due to a surgically or medically correctable condition (e.g., coarctation of the aorta, primary hyperaldosteronism, Cushing’s syndrome, pheochromocytoma, or unilateral renal disease). However, more than 90% of all cases of chronically elevated BP are not secondary to one of these correctable conditions, and are therefore referred to as primary, or essential, hypertension (Whelton & Russell, 1984). The nature of essential hypertension (HBP) has been a topic of controversy for some time (Laragh, 1965). The tendency for an individual to develop HBP often runs in families, and population studies have demonstrated a familial resemblance at all levels of the BP continuum. Environmental stimuli also seem to play a significant role in most cases of HBP (Whelton & Russell, 1984). Predominantly environmental factors that have been implicated in the genesis of HBP are increased ingestion of sodium, excessive caloric intake, and emotional stress. Although BP has been demonstrated to rise in response to diets extremely high in sodium and to fall in response to diets extremely low in sodium, a relationship between dietary salt and HBP still has not been clearly established. Similarly, although weight reduction is often associated with BP reduction, even when dietary sodium and potassium are held constant, obesity is rarely the primary cause of HBP. Acute responses of BP to emotional stress also have not been shown to have a role in the etiology of chronic HBP. The role of other environmental factors (eg., alcohol consumption, cigarette smoking, heavy metal intake, and calcium content of water intake) is also unclear although there is evidence that some role exists in each case (Whelton & Russell, 1984). Because these environmental factors are not mutually exclusive in their influence on BP, the view that HBP has a multifactorial etiology is now gaining wide acceptance.

Keywords

Essential Hypertension Behavioral Treatment Plasma Aldosterone Psychosomatic Medicine Mild Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agras, W. S., and Jacob, R. (1979). Hypertension. In O. F. Pomerleau and J. P. Brady (Eds.), Behavioral medicine: Theory and practice. (pp. 205–232 ), Baltimore, MD: Wiliams and Wilkins.Google Scholar
  2. Agras, W. S., Taylor, C. B., Kraemer, H. C., Allen, R. A., and Schneider, J. A. (1980). Relaxation training: 24-hour blood pressure reductions. Archives of General Psychiatry, 37, 859–865.PubMedCrossRefGoogle Scholar
  3. Agras, W. S., Home, M., and Taylor, C. B. (1982). Expectation and the blood-pressurelowering effects of relaxtion. Psychosomatic Medicine, 44, 389–395.PubMedGoogle Scholar
  4. Agras, W. S., Southam, M. A., and Taylor, C. B. (1983). Long-term persistence of relaxation-induced blood pressure lowering during the working day. Journal of Consulting and Clinical Psychology, 51, 792–794.PubMedCrossRefGoogle Scholar
  5. Agras, W. S., Schneider, J. A., and Taylor, C. B. (1984). Relaxation training in essential hypertension: A failure of retraining in relaxation procedures, Behavioral Therapy, 15, 191–196.CrossRefGoogle Scholar
  6. Alderman, M. H. (1980). The epidemiology of hypertension: Etiology, natural history, and the impact of therapy. Cardiovascular Reviews and Reports, 1, 509–519.Google Scholar
  7. Andrews, G., Macmahon, S. W., Austin, A., and Byrne, D. G. (1982). Hypertension: Comparison of drug and non-drug treatments, British Medical Journal, 284, 1523–1526.PubMedCrossRefGoogle Scholar
  8. Australian National Study (1980). Report by the managmeent committee: The Australian therapeutic trial in mild hypertension, Lancet, 1, 1261–1267.Google Scholar
  9. Bali, L. R. (1979). Long-term effect of relaxation on blood pressure and anxiety levels of essential hypertensive males: A controlled study, Psychosomataic Medicine, 41, 637–646.Google Scholar
  10. Benson, H., Rosner, B. A., and Marzetta, B. R. (1973). Decreased systolic blood pressure in hypertensive subjects who practice meditation. Journal of Clinical Investigation, 52, 8a.Google Scholar
  11. Benson, H., Rosner, B. A., Marzetta, B. R., and Klemchuk, H. P. (1974a). Decreased blood pressure in borderline hypertensive subjects who practiced meditation, Journal of Chronic Diseases, 27, 163–169.PubMedCrossRefGoogle Scholar
  12. Benson, H., Rosner, B. A., Marzetta, B. R., and Klemchuk, H. P. (1974b). Decreased blood pressure in pharmacologically treated hypertensive patients who regularly elicited the relaxation response. Lancet, 1, 289–291.PubMedCrossRefGoogle Scholar
  13. Benson, H. (1975). The relaxation response. New York: William Morrow and Co.Google Scholar
  14. Benson, H., Greenwood, M. M., and Klemchuk, H. (1975). Relaxation response: Psychophysiological aspects and clinical applications. International Journal of Psychiatry in Medicine, 6, 87–98.PubMedCrossRefGoogle Scholar
  15. Blanchard, E. B. (1978). Biofeedback and the modification of cardiovascular dysfunctions. Task Force Report. Wheat Ridge, CO: Biofeedback Society of America.Google Scholar
  16. Brandt, E. N. (1983, November). Advisory on treatment of mild hypertension. FDA Drug Bulletin, 13(3), pp. 24–25.Google Scholar
  17. Charlesworth, E. A., Williams B. J., and Baer, P. E. (1984). Stress management at the worksite for hypertension: Compliance, cost-benefit, health care and hypertension-related variables. Psychosomatic Medicine, 46, 387–397.PubMedGoogle Scholar
  18. Cottier, C., Julius, S., Gajendragadkar, S. V., and Schork, M. A. (1982). Usefulness of home blood pressure determination in treating borderline hypertension. Journal of the American Medical Association, 248, 555–558.PubMedCrossRefGoogle Scholar
  19. Cottier, C., Shapiro, K., and Julius, S. (1984). Treatment of mild hypertension with progressive muscle relaxation: Predictive value of indexes of sympathetic tone. Archives of Internal Medicine, 144, 1954–1958.PubMedCrossRefGoogle Scholar
  20. Datey, K. K. (1980). Role of biofeedback training in hypertension and stress. Journal of Postgraduate Medicine, 26, 68–73.PubMedGoogle Scholar
  21. Davidson, D. M., Winchester, M. A., Taylor, C. B., Alderman, E. A., and Ingels, N. B. (1979). Effects of relaxation therapy on cardiac performance and sympathetic activity in patients with organic heart disease, Psychosomatic Medicine, 41, 303–309.PubMedGoogle Scholar
  22. des Combes, B. J., Porchet, M., Waeber, B., and Brunner, H. R. (1984). Ambulatory blood pressure recordings reproducibility and unpredictability. Hypertension, 6, C110 — C115.PubMedCrossRefGoogle Scholar
  23. Devereux, R. B., Pickering, T. G., Harshfield, G. A., Kleinert, H. D., Denby, L., Clark, L., Pregibon, D., Jason, M., Kleiner, B., Borer, J. S., and Laragh, J. H. (1983). Left ventricular hypertrophy in patients with hypertension: Importance of blood pressure response to regularly recurring stress. Circulation, 68, 470–476.PubMedCrossRefGoogle Scholar
  24. Engel, B. T., Gaarder, K. R., and Glasgow, M. S. (1981). Behavioral treatment of high blood pressure: I. Analyses of intra-and interdaily variations of blood pressure during a one-month, baseline period. Psychosomatic Medicine, 43, 255–270.PubMedGoogle Scholar
  25. Engel, B. T., Glasgow, M. S., and Gaarder, K. R. (1983). Behavioral treatment of high blood pressure: III. Follow-up results and treatment recommendations. Psychosomatic Medicine, 45, 23–29.PubMedGoogle Scholar
  26. Fahrion, S. L. ( 1979, April 3) Addendum: Cardiovascular task force study section report update on biofeedback assisted treatment of essential hypertension. Supplement to biofeedback and the modification of cardiovascular dysfunction. Task Force Report. Wheat Ridge, CO: Biofeedback Society of America.Google Scholar
  27. Floras, J. S., Jones, J. V., Hassan, M. O., Osikowska, B., Sever, P. S., and Sleight, P. (1981). Cuff and ambulatory blood pressure in subjects with essential hypertension. Lancet, 2, 107–109.PubMedCrossRefGoogle Scholar
  28. Frost, R. O., and Holmes, D. S. (1980). Effects of instructions and biofeedback for increasing and decreasing systolic blood pressure. Journal of Psychosomatic Research, 24, 21–27.PubMedCrossRefGoogle Scholar
  29. Gervino, E. V., and Veazey, A. E. (1984). The physiologic effects of Benson’s relaxation response during submaximal aerobic exercise. Journal of Cardiac Rehabilitation, 4, 254–259.Google Scholar
  30. Glasgow, M. S., Gaarder, K. R., and Engel, B. T. (1982). Behavioral treatment of high blood pressure: II. Acute and sustained effects of relaxation and systolic blood pressure biofeedback. Psychosomatic Medicine, 44, 155–170.PubMedGoogle Scholar
  31. Goebel, M., Viol, G. W., Lorenz, G. J., and Clemente, J. (1980). Relaxation and biofeedback in essential hypertension: A preliminary report of a six-year project. American Journal of Clinical Biofeedback, 3, 20–29.Google Scholar
  32. Goldstein, I. B., Shapiro, D., Thananopavarn, C., and Sambhi, M. P. (1982). Comparison of drug and behavioral treatments of essential hypertension. Health Psychology, 1, 7–26.CrossRefGoogle Scholar
  33. Goldstein, I. B., Shapiro, D., and Thananopavarn, C. (1984). Home relaxation techniques for essential hypertension. Psychosomatic Medicine, 46, 398–414.PubMedGoogle Scholar
  34. Gould, B. A., Mann, S., Davies, A. B., Altman, D. G., and Raftery, E. B. (1981, December). Does placebo lower blood-pressure? Lancet, 2, 1377–1381.PubMedCrossRefGoogle Scholar
  35. Green, E. E., Green, A. M., and Norris, P. A. (1980). Self-regulation training for control of hypertension. Primary Cardiology, 6 (3), 126–137.Google Scholar
  36. Hafner, R. J. (1982). Psychological treatment of essential hypertension: A controlled comparison of meditation, and meditation plus biofeedback. Biofeedback and Self-regulation, 7, 305–316.PubMedCrossRefGoogle Scholar
  37. Harshfield, G. A., Pickering, T. G., Kleinert, H. D., Blank, S., and Laragh, J. H. (1982). Situational variations of blood pressure in ambulatory hypertensive patients. Psychosomatic Medicine, 44, 237–245.PubMedGoogle Scholar
  38. Holroyd, J. C., Nuechterlein, K. H., Shapiro, D., and Ward, F. (1982). Individual differences in hypnotizability and effectiveness of hypnosis or biofeedback. International Journal of Clinical and Experimental Hypnosis, 30, 45–65.PubMedCrossRefGoogle Scholar
  39. Hypertension Detection and Follow-up Program Cooperative Group (1979). Five-year findings of the hypertension detection and follow-up program I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Journal of the American Medical Association, 242, 2562–2571.CrossRefGoogle Scholar
  40. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1984). The 1984 Report of the Joint National Committee. Archives of Internal Medicine, 144, 1045–1057.CrossRefGoogle Scholar
  41. Kannel, W. B. (1975). Role of blood pressure in cardiovascular disease. Angiology, 26, 1–14.PubMedCrossRefGoogle Scholar
  42. Kirkendall, W. M., Burton, A. C., Epstein, F. H., and Fries, E. D. (1967). Recommendations for human blood pressure determination by sphygmomanometers. American Heart Association Committee Report, Circulation, 36, 980–988.PubMedCrossRefGoogle Scholar
  43. Kristt, D. A., and Engel, B. T. (1975). Learned control of blood pressure in patients with high blood pressure. Circulation, 51, 370–378.PubMedCrossRefGoogle Scholar
  44. Laragh, J. H. (1965). Recent advances in hypertension. American Journal of Medicine, 39, 616–645.CrossRefGoogle Scholar
  45. Laughlin, K. (1981). Enhancing the effectiveness of behavioral treatments of essential hypertension. Physiology and Behavior, 26, 907–913.PubMedCrossRefGoogle Scholar
  46. Laughlin, K. D., Sherrard, D. J., and Fisher, L. (1980). Compariosn of clinic and home blood pressure levels in essential hypertension and variables associated with clinic home differences. Journal of Chronic Diseases, 33, 197–206.PubMedCrossRefGoogle Scholar
  47. Levinson, P. D., Khatri, I. M., and Freis, E. D. (1982). Persistence of normal BP after withdrawal of drug treatment in mild hypertension. Archives of Internal Medicine, 142, 2265–2268.PubMedCrossRefGoogle Scholar
  48. Libo, L. M., and Arnold, G. E. (1983a). Does training to criterion influence improvement? A follow-up study of EMG and thermal biofeedback. Journal of Behavioral Medicine, 6, 397–404.PubMedCrossRefGoogle Scholar
  49. Libo, L. M., and Arnold, G. E. (1983b). Relaxation practice after biofeedback therapy: A long-term follow-up study of utilization and effectiveness. Biofeedback and Self-Regulation, 8, 217–227.PubMedCrossRefGoogle Scholar
  50. Luborsky, L., Crits-Christoph, P., Brady, J. P., Kron, R. E., Weiss, T., and Engelman, K. (1980, September) Antihypertensive effects of behavioral treatments and medications compared [Letter to the editor]. New England Journal of Medicine, p. 586.Google Scholar
  51. Luborsky, L., Ancona, L., Masoni, A., Scolari, G., and Longoni, A. (1980–81). Behavioral vs pharmacological treatments for essential hypertension. International Journal of Psychiatry in Medicine, 10, 33–40.Google Scholar
  52. Luborsky, L. Crits-Christoph, P., Brady, J. P., Kron, R. E., Weiss, T., Cohen, M., and Levy, L. (1982). Behavioral versus pharmacological treatments for essential hypertension—A needed comparison. Psychosomatic Medicine, 44, 203–213.PubMedGoogle Scholar
  53. Madhaven, S., and Alderman, M. H. (1981). The potential effect of blood pressure reduction on cardiovascular disease. A cautionary note. Archives of Internal Medicine, 141, 1583–1586.CrossRefGoogle Scholar
  54. Mancia, G. (1983). Methods for assessing blood pressure values in humans. Hypertension, 5 (Suppl 3), 5–13.Google Scholar
  55. Manning, D. M., Kuchirka, C., and Kaminski, J. (1983). Miscuffing: inappropriate blood pressure cuff application. Hypertension 68, 763–766.Google Scholar
  56. McAlister, N. H. (1983). Should we treat “mild” hypertension? Journal of the American Medical Association, 249, 379–382.PubMedCrossRefGoogle Scholar
  57. McGrady, A. V., Yonker, R., Tan, S. Y., Fine, T. H., and Woerner, M. (1981). The effect of biofeedback-assisted relaxation training on blood pressure and selected biochemical parameters in patients with essential hypertension. Biofeedback and Self-Regulation, 6, 343–353.PubMedCrossRefGoogle Scholar
  58. McGrady, A., Fine, T., Woerner, M., and Yonker, R. (1983). Maintenance of treatment effects biofeedback-assisted relaxation on patients with essential hypertension. American Journal of Clinical Biofeedback, 6, 34–39.Google Scholar
  59. Messerli, F. H., Decarvalho, J. G. R., Christie, B., and Frohlich, E. D. (1979). Systemic haemodynamic effects of biofeedback in borderline hypertension. Clinical Science, 57, 437s - 439s.PubMedGoogle Scholar
  60. Multiple Risk Factor Intervention Trial Research Group, Risk factor changes and mortality results (1982). Journal of the American Medical Association, 248, 1465–1477.CrossRefGoogle Scholar
  61. Patel, C. (1973). Yoga and biofeedback in the management of hypertension. Lancet, 2(1837), 1053–1055.Google Scholar
  62. Patel, C., and North, W. R. (1975). Randomized controlled trial of yoga and biofeedbck in the management of hypertension. Lancet, 2 (1925), 93–95.PubMedCrossRefGoogle Scholar
  63. Patel, C., Marmot, M. G., and Terry, D. J. (1981). Controlled trial of biofeedback-aided behavioural methods in reducing mild hypertension. British Medical Journal, 282, 2005–2008.Google Scholar
  64. Perloff, D., Sokolow, M., and Cowan, R. (1983). The prognostic value of ambulatory blood pressures. Journal of the American Medical Association, 249, 2792–2798.PubMedCrossRefGoogle Scholar
  65. Pickering, G. (1968). High blood pressure (2nd ed.). New York: Grune and Stratton. Pickering, T. G., (1982). Nonpharmacologic methods of treatment of hypertension: Promising but unproved. Cardiovascular Reviews and Reports, 3, 82–88.Google Scholar
  66. Pickering, T. G., Harshfield, G. A., Kleinert, H. D., Blank, S., and Laragh, J. H. (1982). Blood pressure during normal daily activities, sleep, and exercise: Comparison of values in normal and hypertensive subjects. Journal of the American Medical Association, 247, 992–996.PubMedCrossRefGoogle Scholar
  67. Pickering, T. G., Harshfield, G. A., Kleinert, H. D., and Laragh, J. H. (1982). Ambulatory monitoring in the evaluation of blood pressure in patients with borderline hypertension and the role of the defense reflex. Clinical and Experimental Hypertension, A4(4and5), 675–693.Google Scholar
  68. Richter-Heinrich, E., Homuth, V., Heinrich, B., Schmidt, K-H., Wiedemann, R., and Gohlke, H-R. (1981). Long term application of behavioral treatments in essential hypertensives. Physiology and Behavior, 26, 915–920.PubMedCrossRefGoogle Scholar
  69. Richter-Heinrich, E., Lori, M., Knust, U., and Schmidt, K. H. (1982). Comparison of blood pressure biofeedback and relaxation training in essential hypertension. In E. Richter-Heinrich and N. E. Miller (Eds.), Biofeedback-Basic Problems and Clinical Applications ( 107–120 ). New York: North-Holland.Google Scholar
  70. Richter-Heinrich, E., Homuth, V., Gohlke, H. R., Heinrich, B., Schmidt, K. H., Wiedemann, R., and Heine, H. (1982). Effectiveness of behavioral treatment methods compared to pharmacological therapy and self recordings of blood pressure in essential hypertensives (preliminary report). Activitas Nervosa Superior, Suppl. 3, 422–427.Google Scholar
  71. Richter-Heinrich, E., Homuth, V., Heinrich, B., Knust, U., Schmidt, K. H., and Wiedemann, R. (in press). A long-term controlled study of behavioral treatment in essential hypertension. Activitas Nervosa Superior.Google Scholar
  72. Seer, P., and Raeburn, J. M. (1980). Meditation training and essential hypertension: A methodological study. Journal of Behavioral Medicine, 3, 59–71.PubMedCrossRefGoogle Scholar
  73. Shapiro, A. P., and Jacob, R. G. (1983). Nonpharmacologic approaches to the treatment of hypertension. Annual Review of Public Health, 4, 285–310.PubMedCrossRefGoogle Scholar
  74. Shapiro, D., and Goldstein, I. B. (1982). Biobehavioral perspectives on hypertension. Journal of Consulting and Clinical Psychology, 50, 841–858.PubMedCrossRefGoogle Scholar
  75. Shapiro, D., Turksy, B., Gershon, E., and Stern, M. (1969). Effects of feedback and reinforcement on the control of human systolic blood pressure. Science, 163, 588–590.PubMedCrossRefGoogle Scholar
  76. Shoemaker, J. E., and Tasto, D. L. (1975). The effects of muscle relaxation on blood pressure of essential hypertensives. Behavioral Research and Therapy, 13, 29–43.CrossRefGoogle Scholar
  77. Sokolow, M., Werdegar, D., Kain, H. K., and Hinman, A. T. (1966). Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation, 34, 279–298.PubMedCrossRefGoogle Scholar
  78. Southam, M. A., Agras, W. S., Taylor, C. B., and Kraemer, H. C. (1982). Relaxation training: Blood pressure lowering during the working day. Archives of General Psychiatry, 39, 715–717.PubMedCrossRefGoogle Scholar
  79. Tursky, B., Shapiro, D., and Schwartrz, G. E. (1972). Automated constant-cuff pressure system to measure average systolic and diastolic blood pressure in man. IEEE Transactions in Biomedical Engineering, 19, 271–276.CrossRefGoogle Scholar
  80. VA Cooperative Study Group on Antihypertensive Agents (1970). Effects of treatment on morbidity in hypertension: Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg. Journal of the American Medical Association, 213, 1143–1152.CrossRefGoogle Scholar
  81. VA Cooperative Study Group on Antihypertensive Agents (1975). Return of elevated blood pressure after withdrawal of antihypertensive drugs. Circulation, 51, 1107–1113.CrossRefGoogle Scholar
  82. Vaitl, D., (1982). Psychological management of essential hypertension. Contributions to Nephrology, 30, 87–91.PubMedGoogle Scholar
  83. Wallace, R. K., Benson, H., and Wilson, A. F. (1971). A wakeful hypometabolic physiological state. American Journal of Physiology, 221, 795–799.PubMedGoogle Scholar
  84. Wallace, R. K., and Benson, H. (1972). The physiology of meditation. Scientific American, 226, 84–90.CrossRefGoogle Scholar
  85. Wallace, R. K., Silver, J., Mills, P. J., Dillbeck, M. C., and Wagoner, D. E. (1983). Systolic blood pressure and long-term practice of the transcendental meditation and tm-sidhi program: Effects of tm on systolic blood pressure. Psychosomatic Medicine, 45, 41–46.PubMedGoogle Scholar
  86. Weiss, S. M. (1980). Biobehavioral approaches to the treatment of hypertension. Journal of the South Carolina Medical Association, Suppl. 9, 38–43.Google Scholar
  87. Whelton, P. K., and Russell, R. P. (1984). Systemic hypertension. In A. M. Harvey, R. J. Johns, V. A. McKusick, A. H. Owens, and R. S. Ross (Eds.), The principles and practice of medicine (21st ed., pp. 278–297 ). Norwalk, CT: Appleton-Century-Crofts.Google Scholar
  88. W.H.O./I.S.H. Mild Hypertension Liaison Committee (1982). Trials of the treatment of mild hypertension: An interim analysis. Lancet, 1, 149–156.Google Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Michael S. Glasgow
    • 1
    • 2
    • 3
  • Bernard T. Engel
    • 1
    • 2
    • 3
  1. 1.Gerontology Research CenterBaltimoreUSA
  2. 2.U.S. Department of Health and Human ServicesNational Institute on Aging, National Institutes of HealthBethesdaUSA
  3. 3.Francis Scott Key Medical CenterBaltimoreUSA

Personalised recommendations